Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allan Covens, MD
Toronto Sunnybrook Regional Cancer Centre
- David S. Miller, MD
Simmons Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
Birmingham, Alabama, United States
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Hulston Cancer Center at Cox Medical Center South
Springfield, Missouri, United States
- St. John'S Regional Health Center
Springfield, Missouri, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Blumenthal Cancer Center at Carolinas Medical Center
Charlotte, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Wilson Medical Center
Wilson, North Carolina, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
Columbus, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- Hillcrest Cancer Center at Hillcrest Hospital
Mayfield Heights, Ohio, United States
- Lake/university Ireland Cancer Center
Mentor, Ohio, United States
- Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital
Abington, Pennsylvania, United States
- Mcglinn Family Regional Cancer Center at Reading Hospital and Medical Center
Reading, Pennsylvania, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, United States
- Umc Southwest Cancer and Research Center
Lubbock, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- 23 Jul 2007
- Completion
- —
- Last update posted
- 12 Apr 2018
- Registered enrollment
- 55
- Registry id
- NCT00096187
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.